There are 594 resources available
222P - Adjuvant platinum-based chemotherapy role in stage II-IIIa EGFR-mutated lung cancer: An IPD meta-analysis of phase III randomized controlled trial
Presenter: Riccardo Tajè
Session: Poster Display session
223P - Adjuvant novel tyrosine kinase inhibitors with or without platinum-based chemotherapy for resectable oncogene-addicted NSCLC: An IPD meta-analysis of phase III randomized clinical trials
Presenter: Riccardo Tajè
Session: Poster Display session
224P - Predictive value of FDG PET/CT parameters and T-cell subsets in stage II/III non-small cell lung cancer with neoadjuvant immunotherapy
Presenter: EUN SEONG LEE
Session: Poster Display session
225P - Circulating tumor DNA as a prognostic biomarker in unresectable locally advanced NSCLC
Presenter: Nil Navarro Gorro
Session: Poster Display session
226P - Real-world patient characteristics and TREAtment patterns for stage III in NSCLC in FRance: TREAP
Presenter: christos chouaid
Session: Poster Display session
227P - Prognostic significance of lung immune prognostic Index at diagnosis in stage III non-small cell lung cancer
Presenter: engin kavak
Session: Poster Display session
228P - Type VII collagen enhances matrix viscoelasticity and modulates immune response in advanced lung adenocarcinoma
Presenter: Pengxu Kong
Session: Poster Display session
230P - A retrospective analysis on patterns of surveillance after curative intent treatment for unresectable stage III non-small cell lung cancer (NSCLC)
Presenter: Marie-Frederique Damours
Session: Poster Display session
231P - Prognostic factors for survival in unresectable stage III non-small cell lung cancer (NSCLC) receiving chemoradiotherapy (CRT)
Presenter: Jikai Zhou
Session: Poster Display session
232P - How socioeconomic status (SES) shapes lung adenocarcinoma diagnosis and survival in Brazil: A population-based analysis
Presenter: Fernanda Malucelli Favorito
Session: Poster Display session